EDGAR Pro - INTRA-CELLULAR THERAPIES, INC.

Welcome

Help

About EDGAR® Online

Recent Companies

Company

Summary

Company Info

Risk Factors
(10-Q 08/07/24)

Auditor Opinion & Info

Company News

Industry

Transcripts

Stock Info

Last Trade
$77.61 (+0.64/0.83%)

Interactive Charting

Financials

Balance Sheet

Income Statement

Cash Flow

Financial Ratios

Financial Comparison

SEC Filings

Last MD&A
(10-Q 08/07/24)

Last Quarterly Filing
(10-Q 08/07/24)

Last Annual Filing
(10-K 02/22/24)

Last Proxy Filing
(DEFA14A 04/29/24)

All Filings
(Excluding Insider)

All Filings

All Quarterly Filings

All Annual Filings

All Proxy Filings

SEC Comment Letters
and Correspondence

Ownership

Summary

Insider Trades

Latest Insider Filings

Institutional Holders

5% Ownership Filings

Company People

Executive Compensation

All Company People

Subscribe Now to unlock all the Features!

Learn More

Get Company Summary for

Add Summary to Dashboard

Add Filings Alert

INTRA-CELLULAR THERAPIES, INC. (ITCI)

Summary

Institutional Holders

Total Number of Holders	422
% of Shares Outstanding	91.91%
Total Shares Held	97,120,141
Total Value of Holdings	$7,475,337,252.77
Net Activity	8,489,535

Latest Company News		Date

(Quotes provided by Thomson Reuters are delayed by 15 minutes or more.)

EDGAR® and SEC® are trademarks of the U.S. Securities and Exchange Commission. OTC Markets Group Inc.'s products and services are not affiliated with or approved by the U.S. Securities and Exchange Commission.

EPWWEB-EXT03